JNL/RAFI Multi-Factor U.S. Equity Fund
JNL Series Trust
Fund classification
Classified from what the fund holds · as of 2026 Q2
JNL/RAFI Multi-Factor U.S. Equity Fund is a U.S. equity index fund that tracks the RAFI Multi-Factor US Index. 11% of JNL/RAFI Multi-Factor U.S. Equity Fund’s stock holdings are in companies whose revenue grew in the top quartile of U.S. companies over the last five fiscal years (covering 97% of the fund’s equity).
- Asset class
- Equity
- Region
- United States
- Management
- Index (passive)
- Fund type
- Open-end fund
Fund profile
As filed in the prospectus · 2026 Q2
The investment objective of the Fund is to track the performance of the RAFI Multi-Factor US Index.
The fund tracks the RAFI Multi-Factor US Index by investing substantially all its assets in the index's component securities, which are selected through a rules-based approach that combines five factor portfolios—value, low volatility, quality, momentum, and size—each equally weighted and ranked by fundamental metrics. Day-to-day investment decisions are delegated to Mellon Investments Corporation, the sub-adviser. The index is reconstituted annually and rebalanced quarterly on a staggered schedule, with the momentum factor reconstituted and fully rebalanced each quarter.
| Share class | Expense ratio | As of |
|---|---|---|
| C000210332 | 0.37% | 2025 Q2 |
| C000210333 | 0.67% | 2025 Q2 |
Portfolio turnover 40.00% · as of 2026 Q2
Allocation
Asset groups · long / short shown separately, never netted · 2026 Q2
| Stocks | 99.67% |
| Cash & short-term | 0.77% |
| Derivatives | 0.00% |
Derivatives are shown at market value, not notional exposure.
Sector allocation
The same holdings as Allocation above, grouped by market sector instead of asset type · as of 2026 Q2
| Information Technology | 25.7% |
| Health Care | 14.4% |
| Industrials | 12.7% |
| Financials | 10.3% |
| 10 smaller | 36.9% |
Government, Securitized and Cash are non-corporate buckets; International is foreign holdings we don’t sector-classify, and Other is the residual (held funds, unresolved names).
Portfolio growth profile
How much of the fund’s stock holdings are in fast-growing companies · as of 2026 Q2
Share of the fund’s equity (by value) in companies whose trailing five-year revenue — or net-income — growth ranks in the top 25% of U.S. public companies. Foreign and newly-listed holdings are excluded, so the figure covers only part of the book. From SEC filings — not investment advice. How we measure this.
Latest quarter
What changed since the fund's previous filing
Return profile
Total return as filed — price change plus distributions reinvested · trailing figures to Apr 2026
May 2026 and Jun 2026 have been filed since the trailing figures were struck, so they are not in the table above or the curve — every figure here shares one cut-off, which is what makes them comparable with other funds.
This fund changed legal form during the period shown. The history above is continuous — it spans both eras, and the change is not a gap in reporting.
Holdings
By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page
| Ticker | Issuer | %NAV | Reported price | Value | Shares |
|---|---|---|---|---|---|
| INTC | Intel CorporationINTC | 3.02% | $139.63 | $68.66M | 491.7K |
| WMT | Walmart Inc.WMT | 1.81% | $113.26 | $41.07M | 362.7K |
| LLY | Eli Lilly and CompanyLLY | 1.76% | $1,199.43 | $40.14M | 33.5K |
| AVGO | Broadcom Inc.AVGO | 1.71% | $377.75 | $38.87M | 102.9K |
| JNJ | Johnson & JohnsonJNJ | 1.62% | $253.97 | $36.87M | 145.2K |
| AMAT | Applied Materials, Inc.AMAT | 1.61% | $723.00 | $36.65M | 50.7K |
| LRCX | Lam Research CorporationLRCX | 1.58% | $433.33 | $36.03M | 83.1K |
| XOM | Exxon Mobil CorporationXOM | 1.48% | $136.72 | $33.57M | 245.5K |
| CSCO | Cisco Systems, Inc.CSCO | 1.42% | $117.46 | $32.23M | 274.4K |
| GLW | Corning IncorporatedGLW | 1.37% | $255.43 | $31.19M | 122.1K |
Reported price is the fund's own reported value divided by its own reported shares at 2026-06-30 — not a live quote, and not what the fund paid.
Top 10 positions are 17.38% of net assets, top 25 33.45%, across 884 issuers.
See more of this fund's book
More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.
Sign in free